IJMABHR International Journal of Medical and All Body Health ResearchIJMABHR 2582-8940 Anfo Publication House 136 10.54660/Ijmabhr.2022.3.3.3 Correlation between Pro-inflammatory biomarkers and papillary thyroid cancer: A case control Study PRKBhargav MSabaretnam BGH, Andhra Ratna Road, Gandhi Nagar, Vijayawada, Andhra Pradesh, India 2022 3 3 24 26 03082022 07092022 CC BY-NC-SA 4.0

Introduction: Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy. Apart from genetics, autoimmunity has been implicated in its pathogenesis. In this context, we set out to study the role of Pro- inflammatory cytokines in PTC in South Indian population.rnMaterial and methods: This pilot prospective case-control study was conducted on surgically managed PTC patients. Institutional ethical committee approval was obtained. Diagnosis of PTC was based on imaging, fine needle aspiration cytology and later confirmed by histopathology. Exclusion criteria were subjects with any disease or medication interfering with the hypothalamic-pituitary-gonadal axis. Serum samples were collected from 46 PTC subjects and 44 age matched healthy controls. Interleukin-6 (IL-6), Tumour necrosis factor-alpha (TNF-α) and high sensitive C reactive protein (hsCRP), leptin levels were measured in all serum samples. Statistical analysis was performed by one way ANOVA with Dunnet’s test and Pearson correlation tests.rnResults: The mean hSCRP level in PTC and controls were 18.3 ± 3.1 mg/mL and 5.5 ± 1.2 mg/mL respectively. The mean TNF-α level, IL-6 level and Leptin levels were 295 ± 28 pg/mL, 13.6 ± 4.4 pg/mL and 1.93 ± 0.8 ng/mL respectively. Serum leptin level in controls was 3.6 ±1.8 ng/mL. There was statistically significant difference of all the pro-inflammatory cytokines compared to controls (P value

 Papillary thyroid cancerTumour necrosis factorInterleukin-6GoiterAuto-immunityLeptin References Schlicke CP. Recent trends in thyroid surgery. Am J Surg. 1974; 128:269-275. Clark OH, Greenspan FS, Dunphy JE. Hashimoto’s thyroiditis and thyroid cancer: Indications for operation. Am J Surg. 1980; 140:65-71. Pisanu A, Piu S, Cois A, Uccheddu A. Coexisting Hashimoto’s thyroiditis with differentiated thyroid cancer and benign thyroid diseases: indications for thyroidectomy. Chir Ital. 2003; 55(3):365-372. Carli AF, Lottini M, Testa M, Neri A. Surgical treatment of Hashimoto’s thyroiditis. Personal experience. Minerva Chir. 2002; 57(2):117-122. Kurukahvecioglu O, Taneri F, Yuksel O, Aydin A, Tezel E, Onuk E. Total thyroidectomy for the treatment of Hashimoto’s thyroiditis coexisting with papillary thyroid carcinoma. Adv Ther. 2007; 24(3):510-516. Lai X, Xia Y, Zhang B, Li J, Jiang Y. A meta-analysis of Hashimoto's thyroiditis and papillary thyroid carcinoma risk. Oncotarget. 2017; 8(37):62414-62424. Graceffa G, Patrone R, Vieni S, et al. Association between Hashimoto's thyroiditis and papillary thyroid carcinoma: a retrospective analysis of 305 patients. BMC Endocr Disord. 2019; 19(Suppl 1):26. International Journal of Medical and All Body Health Research www.allmedicaljournal.com Hussein O, Abdelwahab K, Hamdy O, et al. Thyroid cancer associated with Hashimoto thyroiditis: similarities and differences in an endemic area. J Egypt Natl Canc Inst. 2020; 32:7. Beksac K, Sonmez C, Cetin B, Kismali G, Sel T, Tuncer Y, et al. Evaluation of pro inflammatory cytokine and neopterin levels in women with papillary thyroid carcinoma. Int J Biol Markers. 2016; 31(4):e446-e450. Wang W, Chang J, Jia B, Liu J. The Blood Biomarkers of Thyroid Cancer. Cancer Manag Res. 2020; 12:5431-5438. Lin P, Yao Z, Sun Y, Li W, Liu Y, Liang K, et al. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary micro carcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples. J Proteomics. 2019; 204:103414. Mahmoudian-Sani MR, Mehri-Ghahfarrokhi A, Asadi-Samani M, Mobini GR. Serum miRNAs as Biomarkers for the Diagnosis and Prognosis of Thyroid Cancer: A Comprehensive Review of the Literature. Eur Thyroid J. 2017; 6(4):171-177. Wang H, Wang P, Wu Y, Hou X, Peng Z, Yang W, et al. Correlation between obesity and clinicopathological characteristics in patients with papillary thyroid cancer: a study of 1579 cases: A retrospective study. Peer J. 2020; 8:e9675.